HIV

The Pharmacy Times® human immunodeficiency virus (HIV) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
Users will be able to export reports and collect metrics with the new interactive platform, as well as readily access the information on mobile platforms.
[[thumbnail_alt_text]]
The mechanism behind HIV resistance affects the ability of integrase strand transfer inhibitors to bind and block the HIV enzyme integrase.
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
[[thumbnail_alt_text]]
Robust data show the efficacy of tenofovir disoproxil fumarate with emtricitabine for pre-exposure prophylaxis in all priority populations with a risk for HIV.   
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
[[thumbnail_alt_text]]
Antiretroviral therapy may not be entirely effective in restoring the immune protection resulting from viral infections or childhood vaccines received prior to becoming HIV-positive.
 
[[thumbnail_alt_text]]
The app takes the authoritative, evidence-based 2015 World Health Organization pre-exposure prophylaxis guidelines and adapts for a mobile device.
 
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
[[thumbnail_alt_text]]
The loss of immunity, also referred to as “HIV-associated immune amnesia,” could be related to why people with HIV who are on ART still have shorter lives on average than people without HIV, the study noted.  
[[thumbnail_alt_text]]
Recent studies have shown that the HIV virus may affect the brains of children living with and exposed to the virus, even with early antiretroviral therapy (ART). HIV can disrupt neurodevelopment, which affects how children learn, reason, and function.
[[thumbnail_alt_text]]
Study seeks to determine how HIV avoids the zinc-finger antiviral protein and how it binds the RNA.
[[thumbnail_alt_text]]
Individuals with HIV have more QT interval variability than those without the disease, which may lead to the increased risk of sudden cardiac death.